Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Resident Physician Shortage Reduction Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2024 · third_quarter · Q3
FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668), including clarifying HRSA's ability to use OPTN patient waitlist registration fees Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through ESRD PPS/QIP, PFS, and ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Source: Senate LDA
Resident Physician Shortage Reduction Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Increase DoD Congressionally Mandated Medical Research Program Legislation: Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Resident Physician Shortage Reduction Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668), including clarifying HRSA's ability to use OPTN patient waitlist registration fees Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through ESRD PPS/QIP, PFS, and ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Strengthening Medicare for Patients and Providers Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Increase DoD Congressionally Mandated Medical Research Program Legislation: Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Strengthening Medicare for Patients and Providers Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Strengthening Medicare for Patients and Providers Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668), including clarifying HRSA's ability to use OPTN patient waitlist registration fees Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through ESRD PPS/QIP, PFS, and ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Securing the U.S. Organ Procurement and Transplantation Network Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Increase DoD Congressionally Mandated Medical Research Program Legislation: Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Securing the U.S. Organ Procurement and Transplantation Network Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Securing the U.S. Organ Procurement and Transplantation Network Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668), including clarifying HRSA's ability to use OPTN patient waitlist registration fees Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through ESRD PPS/QIP, PFS, and ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Increase DoD Congressionally Mandated Medical Research Program Legislation: Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668), including clarifying HRSA's ability to use OPTN patient waitlist registration fees Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through ESRD PPS/QIP, PFS, and ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Living Donor Protection Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Increase DoD Congressionally Mandated Medical Research Program Legislation: Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Living Donor Protection Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Living Donor Protection Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668), including clarifying HRSA's ability to use OPTN patient waitlist registration fees Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through ESRD PPS/QIP, PFS, and ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Providing Relief and Stability for Medicare Patients Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668), including clarifying HRSA's ability to use OPTN patient waitlist registration fees Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through ESRD PPS/QIP, PFS, and ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Providing Relief and Stability for Medicare Patients Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Providing Relief and Stability for Medicare Patients Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Increase DoD Congressionally Mandated Medical Research Program Legislation: Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Chronic Kidney Disease Improvement in Research and Treatment Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Chronic Kidney Disease Improvement in Research and Treatment Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668), including clarifying HRSA's ability to use OPTN patient waitlist registration fees Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through ESRD PPS/QIP, PFS, and ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Kidney PATIENT Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668), including clarifying HRSA's ability to use OPTN patient waitlist registration fees Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through ESRD PPS/QIP, PFS, and ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Kidney PATIENT Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Increase DoD Congressionally Mandated Medical Research Program Legislation: Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Kidney PATIENT Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Living Organ Donor Tax Credit Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Increase DoD Congressionally Mandated Medical Research Program Legislation: Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Living Organ Donor Tax Credit Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668), including clarifying HRSA's ability to use OPTN patient waitlist registration fees Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through ESRD PPS/QIP, PFS, and ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Living Organ Donor Tax Credit Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Healthcare Workforce Resilience Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668), including clarifying HRSA's ability to use OPTN patient waitlist registration fees Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through ESRD PPS/QIP, PFS, and ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Healthcare Workforce Resilience Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Healthcare Workforce Resilience Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Increase DoD Congressionally Mandated Medical Research Program Legislation: Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Restore Protections for Dialysis Patients Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Restore Protections for Dialysis Patients Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668), including clarifying HRSA's ability to use OPTN patient waitlist registration fees Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through ESRD PPS/QIP, PFS, and ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Restore Protections for Dialysis Patients Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Increase DoD Congressionally Mandated Medical Research Program Legislation: Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Resident Physician Shortage Reduction Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Resident Physician Shortage Reduction Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668), including clarifying HRSA's ability to use OPTN patient waitlist registration fees Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through ESRD PPS/QIP, PFS, and ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Resident Physician Shortage Reduction Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Increase DoD Congressionally Mandated Medical Research Program Legislation: Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Living Donor Protection Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Increase DoD Congressionally Mandated Medical Research Program Legislation: Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Living Donor Protection Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668), including clarifying HRSA's ability to use OPTN patient waitlist registration fees Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through ESRD PPS/QIP, PFS, and ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Living Donor Protection Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Securing the U.S. Organ Procurement and Transplantation Network Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Securing the U.S. Organ Procurement and Transplantation Network Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Increase DoD Congressionally Mandated Medical Research Program Legislation: Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Securing the U.S. Organ Procurement and Transplantation Network Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668), including clarifying HRSA's ability to use OPTN patient waitlist registration fees Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through ESRD PPS/QIP, PFS, and ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Healthcare Workforce Resilience Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Healthcare Workforce Resilience Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Increase DoD Congressionally Mandated Medical Research Program Legislation: Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Healthcare Workforce Resilience Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668), including clarifying HRSA's ability to use OPTN patient waitlist registration fees Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through ESRD PPS/QIP, PFS, and ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Chronic Kidney Disease Improvement in Research and Treatment Act of 2024
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Chronic Kidney Disease Improvement in Research and Treatment Act of 2024
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668), including clarifying HRSA's ability to use OPTN patient waitlist registration fees Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through ESRD PPS/QIP, PFS, and ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Increase DoD Congressionally Mandated Medical Research Program Legislation: Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668), including clarifying HRSA's ability to use OPTN patient waitlist registration fees Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through ESRD PPS/QIP, PFS, and ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Resident Physician Shortage Reduction Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY24 Congressional appropriations: -Increase NIH funds by $3.465 billion, including $168 million increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program by $40 million -Increase DoD Congressionally Mandated Medical Research Program by $15 million Legislation: Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Strengthening Medicare for Patients and Providers Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY24 Congressional appropriations: -Increase NIH funds by $3.465 billion, including $168 million increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program by $40 million -Increase DoD Congressionally Mandated Medical Research Program by $15 million Legislation: Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Securing the U.S. Organ Procurement and Transplantation Network Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY24 Congressional appropriations: -Increase NIH funds by $3.465 billion, including $168 million increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program by $40 million -Increase DoD Congressionally Mandated Medical Research Program by $15 million Other: Pass the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Reintroduce the Living Donor Protection Act (H.R. 2923/S. 1384) Address the health care workforce shortage
Securing the U.S. Organ Procurement and Transplantation Network Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY24 Congressional appropriations: -Increase NIH funds by $3.465 billion, including $168 million increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program by $40 million -Increase DoD Congressionally Mandated Medical Research Program by $15 million Legislation: Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Securing the U.S. Organ Procurement and Transplantation Network Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY24 Congressional appropriations: -Increase NIH funds by $3.465 billion, including $168 million increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program by $40 million -Increase DoD Congressionally Mandated Medical Research Program by $15 million Legislation: Pass the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act and the Living Donor Protection Act (H.R. 2923/S. 1384) Address the health care workforce shortage Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through HRSA OPTN Summer Comment Period Establish a federal screening recommendation for kidney diseases
FY24 Congressional appropriations: -Increase NIH funds by $3.465 billion, including $168 million increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program by $40 million -Increase DoD Congressionally Mandated Medical Research Program by $15 million Legislation: Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Living Donor Protection Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY24 Congressional appropriations: -Increase NIH funds by $3.465 billion, including $168 million increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program by $40 million -Increase DoD Congressionally Mandated Medical Research Program by $15 million Legislation: Pass the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act and the Living Donor Protection Act (H.R. 2923/S. 1384) Address the health care workforce shortage Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through HRSA OPTN Summer Comment Period Establish a federal screening recommendation for kidney diseases
Living Donor Protection Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY24 Congressional appropriations: -Increase NIH funds by $3.465 billion, including $168 million increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program by $40 million -Increase DoD Congressionally Mandated Medical Research Program by $15 million Other: Pass the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Reintroduce the Living Donor Protection Act (H.R. 2923/S. 1384) Address the health care workforce shortage
Living Donor Protection Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY24 Congressional appropriations: -Increase NIH funds by $3.465 billion, including $168 million increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program by $40 million -Increase DoD Congressionally Mandated Medical Research Program by $15 million Legislation: Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Providing Relief and Stability for Medicare Patients Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY24 Congressional appropriations: -Increase NIH funds by $3.465 billion, including $168 million increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program by $40 million -Increase DoD Congressionally Mandated Medical Research Program by $15 million Legislation: Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Kidney PATIENT Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY24 Congressional appropriations: -Increase NIH funds by $3.465 billion, including $168 million increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program by $40 million -Increase DoD Congressionally Mandated Medical Research Program by $15 million Legislation: Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Living Organ Donor Tax Credit Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY24 Congressional appropriations: -Increase NIH funds by $3.465 billion, including $168 million increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program by $40 million -Increase DoD Congressionally Mandated Medical Research Program by $15 million Legislation: Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Healthcare Workforce Resilience Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY24 Congressional appropriations: -Increase NIH funds by $3.465 billion, including $168 million increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program by $40 million -Increase DoD Congressionally Mandated Medical Research Program by $15 million Legislation: Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Restore Protections for Dialysis Patients Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY24 Congressional appropriations: -Increase NIH funds by $3.465 billion, including $168 million increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program by $40 million -Increase DoD Congressionally Mandated Medical Research Program by $15 million Legislation: Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Resident Physician Shortage Reduction Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY24 Congressional appropriations: -Increase NIH funds by $3.465 billion, including $168 million increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program by $40 million -Increase DoD Congressionally Mandated Medical Research Program by $15 million Legislation: Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Living Donor Protection Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY24 Congressional appropriations: -Increase NIH funds by $3.465 billion, including $168 million increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program by $40 million -Increase DoD Congressionally Mandated Medical Research Program by $15 million Legislation: Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Living Donor Protection Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY24 Congressional appropriations: -Increase NIH funds by $3.465 billion, including $168 million increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program by $40 million -Increase DoD Congressionally Mandated Medical Research Program by $15 million Other: Pass the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Reintroduce the Living Donor Protection Act (H.R. 2923/S. 1384) Address the health care workforce shortage
Living Donor Protection Act of 2023
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY24 Congressional appropriations: -Increase NIH funds by $3.465 billion, including $168 million increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program by $40 million -Increase DoD Congressionally Mandated Medical Research Program by $15 million Legislation: Pass the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act and the Living Donor Protection Act (H.R. 2923/S. 1384) Address the health care workforce shortage Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through HRSA OPTN Summer Comment Period Establish a federal screening recommendation for kidney diseases
Securing the U.S. Organ Procurement and Transplantation Network Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY24 Congressional appropriations: -Increase NIH funds by $3.465 billion, including $168 million increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program by $40 million -Increase DoD Congressionally Mandated Medical Research Program by $15 million Legislation: Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Securing the U.S. Organ Procurement and Transplantation Network Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY24 Congressional appropriations: -Increase NIH funds by $3.465 billion, including $168 million increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program by $40 million -Increase DoD Congressionally Mandated Medical Research Program by $15 million Other: Pass the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Reintroduce the Living Donor Protection Act (H.R. 2923/S. 1384) Address the health care workforce shortage
Securing the U.S. Organ Procurement and Transplantation Network Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY24 Congressional appropriations: -Increase NIH funds by $3.465 billion, including $168 million increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program by $40 million -Increase DoD Congressionally Mandated Medical Research Program by $15 million Legislation: Pass the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act and the Living Donor Protection Act (H.R. 2923/S. 1384) Address the health care workforce shortage Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through HRSA OPTN Summer Comment Period Establish a federal screening recommendation for kidney diseases
Healthcare Workforce Resilience Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY24 Congressional appropriations: -Increase NIH funds by $3.465 billion, including $168 million increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program by $40 million -Increase DoD Congressionally Mandated Medical Research Program by $15 million Legislation: Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
FY24 Congressional appropriations: -Increase NIH funds by $3.465 billion, including $168 million increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program by $40 million -Increase DoD Congressionally Mandated Medical Research Program by $15 million Legislation: Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Living Donor Protection Act of 2021
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY23 Congressional appropriations: -Increase NIH funds, including $632 million increase for NIDDK to support kidney research and prioritizing research to improve the diagnosis of kidney diseases and health equity interventions -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $15 million Other: -Enact the Living Donor Protection Act (HR1255 S377) -Enact the Restore Protections for Dialysis Patients Act (HR8594/S4750) -Enact the Jack Reyonlds Medigap Expansion Act (HR1676) -Enact the Improving Access to Home Dialysis Act of (HR5426) -Enact the Medical Nutrition Therapy Act (HR3108 S1536) -Enact the Health Equity and Accountability Act (HR7585) -Increase transparency and accountability in the US transplant system -Address Clinical Labor Cuts impacting vascular access in FY 23 Medicare Physician Fee Schedule
Living Donor Protection Act of 2021
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY22 Congressional appropriations: -Increase NIH funds, supporting $6.5 billion for NIH in general including $2.2 billion for kidney research at NIDDK -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $5 million FY23 Congressional appropriations: -Increase NIH funds, including $632 million increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $15 million Other: -Enact the Living Donor Protection Act (HR1255 S377) -Enact the Jack Reyonlds Medigap Expansion Act (HR1676) -Enact the Improving Access to Home Dialysis Act of (HR5426)
Living Donor Protection Act of 2021
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY23 Congressional appropriations: -Increase NIH funds, including $632 million increase for NIDDK to support kidney research and prioritizing research to improve the diagnosis of kidney diseases and health equity interventions -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $15 million Other: -Enact the Living Donor Protection Act (HR1255 S377) -Enact the Jack Reyonlds Medigap Expansion Act (HR1676) -Enact the Improving Access to Home Dialysis Act of (HR5426) -Enact the Medical Nutrition Therapy Act (HR3108 S1536) -Enact the Health Equity and Accountability Act (HR7585) -Increase transparency and accountability in the US transplant system -Address conversion factor physician payment cuts in the FY 23 Medicare Physician Fee Schedule -Address Clinical Labor Cuts impacting vascular access in the FY 23 Medicare Physician Fee Schedule -Address the impact of changes to Medicare Secondary Payer policy on access to care
Living Donor Protection Act of 2021
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY22 Congressional appropriations: -Increase NIH funds, supporting $6.5 billion for NIH in general including $2.2 billion for kidney research at NIDDK -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $5 million FY23 Congressional appropriations: -Increase NIH funds, including $632 million increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $15 million Other: -Enact the Living Donor Protection Act (HR1255 S377) -Enact the Jack Reyonlds Medigap Expansion Act (HR1676) -Enact the Improving Access to Home Dialysis Act of (HR5426)
Living Donor Protection Act of 2021
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY23 Congressional appropriations: -Increase NIH funds, including $632 million increase for NIDDK to support kidney research and prioritizing research to improve the diagnosis of kidney diseases and health equity interventions -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $15 million Other: -Enact the Living Donor Protection Act (HR1255 S377) -Enact the Jack Reyonlds Medigap Expansion Act (HR1676) -Enact the Improving Access to Home Dialysis Act of (HR5426) -Enact the Medical Nutrition Therapy Act (HR3108 S1536) -Enact the Health Equity and Accountability Act (HR7585) -Address Clinical Labor Cuts impacting vascular access in FY 23 Medicare Physician Fee Schedule
Jack Reynolds Memory Medigap Expansion Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY22 Congressional appropriations: -Increase NIH funds, supporting $6.5 billion for NIH in general including $2.2 billion for kidney research at NIDDK -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $5 million FY23 Congressional appropriations: -Increase NIH funds, including $632 million increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $15 million Other: -Enact the Living Donor Protection Act (HR1255 S377) -Enact the Jack Reyonlds Medigap Expansion Act (HR1676) -Enact the Improving Access to Home Dialysis Act of (HR5426)
Jack Reynolds Memory Medigap Expansion Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY23 Congressional appropriations: -Increase NIH funds, including $632 million increase for NIDDK to support kidney research and prioritizing research to improve the diagnosis of kidney diseases and health equity interventions -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $15 million Other: -Enact the Living Donor Protection Act (HR1255 S377) -Enact the Jack Reyonlds Medigap Expansion Act (HR1676) -Enact the Improving Access to Home Dialysis Act of (HR5426) -Enact the Medical Nutrition Therapy Act (HR3108 S1536) -Enact the Health Equity and Accountability Act (HR7585) -Increase transparency and accountability in the US transplant system -Address conversion factor physician payment cuts in the FY 23 Medicare Physician Fee Schedule -Address Clinical Labor Cuts impacting vascular access in the FY 23 Medicare Physician Fee Schedule -Address the impact of changes to Medicare Secondary Payer policy on access to care
Jack Reynolds Memory Medigap Expansion Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY23 Congressional appropriations: -Increase NIH funds, including $632 million increase for NIDDK to support kidney research and prioritizing research to improve the diagnosis of kidney diseases and health equity interventions -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $15 million Other: -Enact the Living Donor Protection Act (HR1255 S377) -Enact the Jack Reyonlds Medigap Expansion Act (HR1676) -Enact the Improving Access to Home Dialysis Act of (HR5426) -Enact the Medical Nutrition Therapy Act (HR3108 S1536) -Enact the Health Equity and Accountability Act (HR7585) -Address Clinical Labor Cuts impacting vascular access in FY 23 Medicare Physician Fee Schedule
Jack Reynolds Memory Medigap Expansion Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY22 Congressional appropriations: -Increase NIH funds, supporting $6.5 billion for NIH in general including $2.2 billion for kidney research at NIDDK -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $5 million FY23 Congressional appropriations: -Increase NIH funds, including $632 million increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $15 million Other: -Enact the Living Donor Protection Act (HR1255 S377) -Enact the Jack Reyonlds Medigap Expansion Act (HR1676) -Enact the Improving Access to Home Dialysis Act of (HR5426)
Jack Reynolds Memory Medigap Expansion Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY23 Congressional appropriations: -Increase NIH funds, including $632 million increase for NIDDK to support kidney research and prioritizing research to improve the diagnosis of kidney diseases and health equity interventions -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $15 million Other: -Enact the Living Donor Protection Act (HR1255 S377) -Enact the Restore Protections for Dialysis Patients Act (HR8594/S4750) -Enact the Jack Reyonlds Medigap Expansion Act (HR1676) -Enact the Improving Access to Home Dialysis Act of (HR5426) -Enact the Medical Nutrition Therapy Act (HR3108 S1536) -Enact the Health Equity and Accountability Act (HR7585) -Increase transparency and accountability in the US transplant system -Address Clinical Labor Cuts impacting vascular access in FY 23 Medicare Physician Fee Schedule
Medical Nutrition Therapy Act of 2021
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY23 Congressional appropriations: -Increase NIH funds, including $632 million increase for NIDDK to support kidney research and prioritizing research to improve the diagnosis of kidney diseases and health equity interventions -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $15 million Other: -Enact the Living Donor Protection Act (HR1255 S377) -Enact the Jack Reyonlds Medigap Expansion Act (HR1676) -Enact the Improving Access to Home Dialysis Act of (HR5426) -Enact the Medical Nutrition Therapy Act (HR3108 S1536) -Enact the Health Equity and Accountability Act (HR7585) -Increase transparency and accountability in the US transplant system -Address conversion factor physician payment cuts in the FY 23 Medicare Physician Fee Schedule -Address Clinical Labor Cuts impacting vascular access in the FY 23 Medicare Physician Fee Schedule -Address the impact of changes to Medicare Secondary Payer policy on access to care
Medical Nutrition Therapy Act of 2021
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY23 Congressional appropriations: -Increase NIH funds, including $632 million increase for NIDDK to support kidney research and prioritizing research to improve the diagnosis of kidney diseases and health equity interventions -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $15 million Other: -Enact the Living Donor Protection Act (HR1255 S377) -Enact the Restore Protections for Dialysis Patients Act (HR8594/S4750) -Enact the Jack Reyonlds Medigap Expansion Act (HR1676) -Enact the Improving Access to Home Dialysis Act of (HR5426) -Enact the Medical Nutrition Therapy Act (HR3108 S1536) -Enact the Health Equity and Accountability Act (HR7585) -Increase transparency and accountability in the US transplant system -Address Clinical Labor Cuts impacting vascular access in FY 23 Medicare Physician Fee Schedule
Medical Nutrition Therapy Act of 2021
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY23 Congressional appropriations: -Increase NIH funds, including $632 million increase for NIDDK to support kidney research and prioritizing research to improve the diagnosis of kidney diseases and health equity interventions -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $15 million Other: -Enact the Living Donor Protection Act (HR1255 S377) -Enact the Jack Reyonlds Medigap Expansion Act (HR1676) -Enact the Improving Access to Home Dialysis Act of (HR5426) -Enact the Medical Nutrition Therapy Act (HR3108 S1536) -Enact the Health Equity and Accountability Act (HR7585) -Address Clinical Labor Cuts impacting vascular access in FY 23 Medicare Physician Fee Schedule
Improving Access to Home Dialysis Act of 2021
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY23 Congressional appropriations: -Increase NIH funds, including $632 million increase for NIDDK to support kidney research and prioritizing research to improve the diagnosis of kidney diseases and health equity interventions -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $15 million Other: -Enact the Living Donor Protection Act (HR1255 S377) -Enact the Restore Protections for Dialysis Patients Act (HR8594/S4750) -Enact the Jack Reyonlds Medigap Expansion Act (HR1676) -Enact the Improving Access to Home Dialysis Act of (HR5426) -Enact the Medical Nutrition Therapy Act (HR3108 S1536) -Enact the Health Equity and Accountability Act (HR7585) -Increase transparency and accountability in the US transplant system -Address Clinical Labor Cuts impacting vascular access in FY 23 Medicare Physician Fee Schedule
Improving Access to Home Dialysis Act of 2021
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY23 Congressional appropriations: -Increase NIH funds, including $632 million increase for NIDDK to support kidney research and prioritizing research to improve the diagnosis of kidney diseases and health equity interventions -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $15 million Other: -Enact the Living Donor Protection Act (HR1255 S377) -Enact the Jack Reyonlds Medigap Expansion Act (HR1676) -Enact the Improving Access to Home Dialysis Act of (HR5426) -Enact the Medical Nutrition Therapy Act (HR3108 S1536) -Enact the Health Equity and Accountability Act (HR7585) -Address Clinical Labor Cuts impacting vascular access in FY 23 Medicare Physician Fee Schedule
Improving Access to Home Dialysis Act of 2021
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY23 Congressional appropriations: -Increase NIH funds, including $632 million increase for NIDDK to support kidney research and prioritizing research to improve the diagnosis of kidney diseases and health equity interventions -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $15 million Other: -Enact the Living Donor Protection Act (HR1255 S377) -Enact the Jack Reyonlds Medigap Expansion Act (HR1676) -Enact the Improving Access to Home Dialysis Act of (HR5426) -Enact the Medical Nutrition Therapy Act (HR3108 S1536) -Enact the Health Equity and Accountability Act (HR7585) -Increase transparency and accountability in the US transplant system -Address conversion factor physician payment cuts in the FY 23 Medicare Physician Fee Schedule -Address Clinical Labor Cuts impacting vascular access in the FY 23 Medicare Physician Fee Schedule -Address the impact of changes to Medicare Secondary Payer policy on access to care
Improving Access to Home Dialysis Act of 2021
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY22 Congressional appropriations: -Increase NIH funds, supporting $6.5 billion for NIH in general including $2.2 billion for kidney research at NIDDK -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $5 million FY23 Congressional appropriations: -Increase NIH funds, including $632 million increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $15 million Other: -Enact the Living Donor Protection Act (HR1255 S377) -Enact the Jack Reyonlds Medigap Expansion Act (HR1676) -Enact the Improving Access to Home Dialysis Act of (HR5426)
Improving Access to Home Dialysis Act of 2021
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY22 Congressional appropriations: -Increase NIH funds, supporting $6.5 billion for NIH in general including $2.2 billion for kidney research at NIDDK -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $5 million FY23 Congressional appropriations: -Increase NIH funds, including $632 million increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $15 million Other: -Enact the Living Donor Protection Act (HR1255 S377) -Enact the Jack Reyonlds Medigap Expansion Act (HR1676) -Enact the Improving Access to Home Dialysis Act of (HR5426)
Health Equity and Accountability Act of 2022
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY23 Congressional appropriations: -Increase NIH funds, including $632 million increase for NIDDK to support kidney research and prioritizing research to improve the diagnosis of kidney diseases and health equity interventions -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $15 million Other: -Enact the Living Donor Protection Act (HR1255 S377) -Enact the Restore Protections for Dialysis Patients Act (HR8594/S4750) -Enact the Jack Reyonlds Medigap Expansion Act (HR1676) -Enact the Improving Access to Home Dialysis Act of (HR5426) -Enact the Medical Nutrition Therapy Act (HR3108 S1536) -Enact the Health Equity and Accountability Act (HR7585) -Increase transparency and accountability in the US transplant system -Address Clinical Labor Cuts impacting vascular access in FY 23 Medicare Physician Fee Schedule
Health Equity and Accountability Act of 2022
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY23 Congressional appropriations: -Increase NIH funds, including $632 million increase for NIDDK to support kidney research and prioritizing research to improve the diagnosis of kidney diseases and health equity interventions -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $15 million Other: -Enact the Living Donor Protection Act (HR1255 S377) -Enact the Jack Reyonlds Medigap Expansion Act (HR1676) -Enact the Improving Access to Home Dialysis Act of (HR5426) -Enact the Medical Nutrition Therapy Act (HR3108 S1536) -Enact the Health Equity and Accountability Act (HR7585) -Increase transparency and accountability in the US transplant system -Address conversion factor physician payment cuts in the FY 23 Medicare Physician Fee Schedule -Address Clinical Labor Cuts impacting vascular access in the FY 23 Medicare Physician Fee Schedule -Address the impact of changes to Medicare Secondary Payer policy on access to care
Health Equity and Accountability Act of 2022
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY23 Congressional appropriations: -Increase NIH funds, including $632 million increase for NIDDK to support kidney research and prioritizing research to improve the diagnosis of kidney diseases and health equity interventions -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $15 million Other: -Enact the Living Donor Protection Act (HR1255 S377) -Enact the Jack Reyonlds Medigap Expansion Act (HR1676) -Enact the Improving Access to Home Dialysis Act of (HR5426) -Enact the Medical Nutrition Therapy Act (HR3108 S1536) -Enact the Health Equity and Accountability Act (HR7585) -Address Clinical Labor Cuts impacting vascular access in FY 23 Medicare Physician Fee Schedule
Restore Protections for Dialysis Patients Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY23 Congressional appropriations: -Increase NIH funds, including $632 million increase for NIDDK to support kidney research and prioritizing research to improve the diagnosis of kidney diseases and health equity interventions -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $15 million Other: -Enact the Living Donor Protection Act (HR1255 S377) -Enact the Restore Protections for Dialysis Patients Act (HR8594/S4750) -Enact the Jack Reyonlds Medigap Expansion Act (HR1676) -Enact the Improving Access to Home Dialysis Act of (HR5426) -Enact the Medical Nutrition Therapy Act (HR3108 S1536) -Enact the Health Equity and Accountability Act (HR7585) -Increase transparency and accountability in the US transplant system -Address Clinical Labor Cuts impacting vascular access in FY 23 Medicare Physician Fee Schedule
Medical Nutrition Therapy Act of 2021
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY23 Congressional appropriations: -Increase NIH funds, including $632 million increase for NIDDK to support kidney research and prioritizing research to improve the diagnosis of kidney diseases and health equity interventions -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $15 million Other: -Enact the Living Donor Protection Act (HR1255 S377) -Enact the Jack Reyonlds Medigap Expansion Act (HR1676) -Enact the Improving Access to Home Dialysis Act of (HR5426) -Enact the Medical Nutrition Therapy Act (HR3108 S1536) -Enact the Health Equity and Accountability Act (HR7585) -Address Clinical Labor Cuts impacting vascular access in FY 23 Medicare Physician Fee Schedule
Medical Nutrition Therapy Act of 2021
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY23 Congressional appropriations: -Increase NIH funds, including $632 million increase for NIDDK to support kidney research and prioritizing research to improve the diagnosis of kidney diseases and health equity interventions -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $15 million Other: -Enact the Living Donor Protection Act (HR1255 S377) -Enact the Restore Protections for Dialysis Patients Act (HR8594/S4750) -Enact the Jack Reyonlds Medigap Expansion Act (HR1676) -Enact the Improving Access to Home Dialysis Act of (HR5426) -Enact the Medical Nutrition Therapy Act (HR3108 S1536) -Enact the Health Equity and Accountability Act (HR7585) -Increase transparency and accountability in the US transplant system -Address Clinical Labor Cuts impacting vascular access in FY 23 Medicare Physician Fee Schedule
Medical Nutrition Therapy Act of 2021
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY23 Congressional appropriations: -Increase NIH funds, including $632 million increase for NIDDK to support kidney research and prioritizing research to improve the diagnosis of kidney diseases and health equity interventions -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $15 million Other: -Enact the Living Donor Protection Act (HR1255 S377) -Enact the Jack Reyonlds Medigap Expansion Act (HR1676) -Enact the Improving Access to Home Dialysis Act of (HR5426) -Enact the Medical Nutrition Therapy Act (HR3108 S1536) -Enact the Health Equity and Accountability Act (HR7585) -Increase transparency and accountability in the US transplant system -Address conversion factor physician payment cuts in the FY 23 Medicare Physician Fee Schedule -Address Clinical Labor Cuts impacting vascular access in the FY 23 Medicare Physician Fee Schedule -Address the impact of changes to Medicare Secondary Payer policy on access to care
Living Donor Protection Act of 2021
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY22 Congressional appropriations: -Increase NIH funds, supporting $6.5 billion for NIH in general including $2.2 billion for kidney research at NIDDK -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $5 million FY23 Congressional appropriations: -Increase NIH funds, including $632 million increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $15 million Other: -Enact the Living Donor Protection Act (HR1255 S377) -Enact the Jack Reyonlds Medigap Expansion Act (HR1676) -Enact the Improving Access to Home Dialysis Act of (HR5426)
Living Donor Protection Act of 2021
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY23 Congressional appropriations: -Increase NIH funds, including $632 million increase for NIDDK to support kidney research and prioritizing research to improve the diagnosis of kidney diseases and health equity interventions -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $15 million Other: -Enact the Living Donor Protection Act (HR1255 S377) -Enact the Jack Reyonlds Medigap Expansion Act (HR1676) -Enact the Improving Access to Home Dialysis Act of (HR5426) -Enact the Medical Nutrition Therapy Act (HR3108 S1536) -Enact the Health Equity and Accountability Act (HR7585) -Address Clinical Labor Cuts impacting vascular access in FY 23 Medicare Physician Fee Schedule
Living Donor Protection Act of 2021
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
FY23 Congressional appropriations: -Increase NIH funds, including $632 million increase for NIDDK to support kidney research and prioritizing research to improve the diagnosis of kidney diseases and health equity interventions -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $15 million Other: -Enact the Living Donor Protection Act (HR1255 S377) -Enact the Jack Reyonlds Medigap Expansion Act (HR1676) -Enact the Improving Access to Home Dialysis Act of (HR5426) -Enact the Medical Nutrition Therapy Act (HR3108 S1536) -Enact the Health Equity and Accountability Act (HR7585) -Increase transparency and accountability in the US transplant system -Address conversion factor physician payment cuts in the FY 23 Medicare Physician Fee Schedule -Address Clinical Labor Cuts impacting vascular access in the FY 23 Medicare Physician Fee Schedule -Address the impact of changes to Medicare Secondary Payer policy on access to care
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program Regulatory: Prioritize kidney health research, including inside the NIH Ensure training grants established by the NIH are supportive of the kidney health workforce
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2024 · second_quarter · Q2
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program Regulatory: Prioritize kidney health research, including inside the NIH Ensure training grants established by the NIH are supportive of the kidney health workforce
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), the Chronic Kidney Disease Research and Treatment Act, (H.R. 5027/S. 4469), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2024 · first_quarter · Q1
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Increase DoD Congressionally Mandated Medical Research Program Regulatory: Prioritize kidney health research, including inside the NIH
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Increase DoD Congressionally Mandated Medical Research Program Legislation: Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2023 · fourth_quarter · Q4
FY24 Congressional appropriations: -Increase NIH funds by $3.465 billion, including $168 million increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program by $40 million -Increase DoD Congressionally Mandated Medical Research Program by $15 million Legislation: Support implementation of the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice by passing the Kidney PATIENT Act (H.R. 5074), the Restore Protections for Dialysis Patients Act (H.R. 6860), and the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) Bolster the kidney health care workforce, including by passing the Healthcare Workforce Resilience Act (H.R. 6205/S. 3211), the Strengthening Medicare for Patients and Providers Act (HR 2474), The Specialty Physicians Advancing Rural Care Act (S. 705/ H.R. 2761), and the Resident Physician Shortage Act (HR 2389/S. 1302) Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases
Legislative: FY24 Congressional appropriations: -Increase NIH funds by $3.465 billion, including $168 million increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program by $40 million -Increase DoD Congressionally Mandated Medical Research Program by $15 million Regulatory: Prioritize kidney health research, including inside the NIH
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2023 · third_quarter · Q3
FY24 Congressional appropriations: -Increase NIH funds by $3.465 billion, including $168 million increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program by $40 million -Increase DoD Congressionally Mandated Medical Research Program by $15 million Legislation: Pass the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Increase support for living donors including through the Honor Our Living Donors Act and the Living Donor Protection Act (H.R. 2923/S. 1384) Address the health care workforce shortage Regulatory: Increase kidney health coordination, innovation, and reimbursement through CY24 ESRD PPS/QIP, CY24 PFS, and 2023 ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through HRSA OPTN Summer Comment Period Establish a federal screening recommendation for kidney diseases
FY24 Congressional appropriations: -Increase NIH funds by $3.465 billion, including $168 million increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program by $40 million -Increase DoD Congressionally Mandated Medical Research Program by $15 million
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2023 · second_quarter · Q2
FY24 Congressional appropriations: -Increase NIH funds by $3.465 billion, including $168 million increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program by $40 million -Increase DoD Congressionally Mandated Medical Research Program by $15 million Other: Pass the Securing the U.S. Organ Procurement and Transplantation Act (H.R. 2544/S. 1668) Reintroduce the Living Donor Protection Act (H.R. 2923/S. 1384) Address the health care workforce shortage
FY24 Congressional appropriations: -Increase NIH funds by $3.465 billion, including $168 million increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program by $40 million -Increase DoD Congressionally Mandated Medical Research Program by $15 million
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2023 · first_quarter · Q1
FY24 Congressional appropriations: -Increase NIH funds by $3.465 billion, including $168 million increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program by $40 million -Increase DoD Congressionally Mandated Medical Research Program by $15 million
FY24 Congressional appropriations: -Increase NIH funds by $3.465 billion, including $168 million increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program by $40 million -Increase DoD Congressionally Mandated Medical Research Program by $15 million Other: Increase transparency and accountability in the US transplant system Reintroduce the Living Donor Protection Act Address the health care workforce shortage
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2022 · fourth_quarter · Q4
FY23 Congressional appropriations: -Increase NIH funds, including $632 million increase for NIDDK to support kidney research and prioritizing research to improve the diagnosis of kidney diseases and health equity interventions -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $15 million Other: -Enact the Living Donor Protection Act (HR1255 S377) -Enact the Jack Reyonlds Medigap Expansion Act (HR1676) -Enact the Improving Access to Home Dialysis Act of (HR5426) -Enact the Medical Nutrition Therapy Act (HR3108 S1536) -Enact the Health Equity and Accountability Act (HR7585) -Increase transparency and accountability in the US transplant system -Address conversion factor physician payment cuts in the FY 23 Medicare Physician Fee Schedule -Address Clinical Labor Cuts impacting vascular access in the FY 23 Medicare Physician Fee Schedule -Address the impact of changes to Medicare Secondary Payer policy on access to care
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2022 · third_quarter · Q3
FY23 Congressional appropriations: -Increase NIH funds, including $632 million increase for NIDDK to support kidney research and prioritizing research to improve the diagnosis of kidney diseases and health equity interventions -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $15 million Other: -Enact the Living Donor Protection Act (HR1255 S377) -Enact the Restore Protections for Dialysis Patients Act (HR8594/S4750) -Enact the Jack Reyonlds Medigap Expansion Act (HR1676) -Enact the Improving Access to Home Dialysis Act of (HR5426) -Enact the Medical Nutrition Therapy Act (HR3108 S1536) -Enact the Health Equity and Accountability Act (HR7585) -Increase transparency and accountability in the US transplant system -Address Clinical Labor Cuts impacting vascular access in FY 23 Medicare Physician Fee Schedule
FY22 Congressional appropriations: -Increase NIH funds, including $632 million increase for NIDDK to support kidney research and prioritizing research to improve the diagnosis of kidney diseases and health equity interventions -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $15 million
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2022 · second_quarter · 2A
FY23 Congressional appropriations: -Increase NIH funds, including $632 million increase for NIDDK to support kidney research and prioritizing research to improve the diagnosis of kidney diseases and health equity interventions -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $15 million Other: -Enact the Living Donor Protection Act (HR1255 S377) -Enact the Jack Reyonlds Medigap Expansion Act (HR1676) -Enact the Improving Access to Home Dialysis Act of (HR5426) -Enact the Medical Nutrition Therapy Act (HR3108 S1536) -Enact the Health Equity and Accountability Act (HR7585) -Address Clinical Labor Cuts impacting vascular access in FY 23 Medicare Physician Fee Schedule
FY22 Congressional appropriations: -Increase NIH funds, including $632 million increase for NIDDK to support kidney research and prioritizing research to improve the diagnosis of kidney diseases and health equity interventions -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $15 million
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2022 · second_quarter · Q2
FY22 Congressional appropriations: -Increase NIH funds, including $632 million increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $15 million
FY22 Congressional appropriations: -Increase NIH funds, supporting $6.5 billion for NIH in general including $2.2 billion for kidney research at NIDDK -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $5 million FY23 Congressional appropriations: -Increase NIH funds, including $632 million increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $15 million Other: -Enact the Living Donor Protection Act (HR1255 S377) -Enact the Jack Reyonlds Medigap Expansion Act (HR1676) -Enact the Improving Access to Home Dialysis Act of (HR5426)
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2022 · first_quarter · Q1
FY22 Congressional appropriations: -Increase NIH funds, including $632 million increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $15 million
FY22 Congressional appropriations: -Increase NIH funds, supporting $6.5 billion for NIH in general including $2.2 billion for kidney research at NIDDK -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $5 million FY23 Congressional appropriations: -Increase NIH funds, including $632 million increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $15 million Other: -Enact the Living Donor Protection Act (HR1255 S377) -Enact the Jack Reyonlds Medigap Expansion Act (HR1676) -Enact the Improving Access to Home Dialysis Act of (HR5426)
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2021 · fourth_quarter · Q4
FY22 Congressional appropriations: -Increase NIH funds, supporting $6.5 billion for NIH in general including $2.2 billion for kidney research at NIDDK -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $5 million Other: -Enact the Living Donor Protection Act (HR1255 S377) -Enact the Jack Reyonlds Medigap Expansion Act (HR1676) -Enable access to telehealth by removing home and originating site restrictions in statute, as in the CONNECT for Health Act (H.R. 2903/S. 1512)
FY22 Congressional appropriations: -Increase NIH funds, supporting $6.5 billion for NIH in general, including $2.2 billion for kidney research at NIDDK -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $5 million
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2021 · third_quarter · Q3
FY22 Congressional appropriations: -Increase NIH funds, supporting $6.5 billion for NIH in general, including $2.2 billion for kidney research at NIDDK -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $5 million
-Access to COVID-19 vaccines and boosters for people with kidney diseases, including transplantation and dialysis
FY22 Congressional appropriations: -Increase NIH funds, supporting $6.5 billion for NIH in general including $2.2 billion for kidney research at NIDDK -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $5 million Other: -Enact the Living Donor Protection Act (HR1255 S377) -Enact the Jack Reyonlds Medigap Expansion Act (HR1676) -Enable access to telehealth by removing home and originating site restrictions in statute, as in the CONNECT for Health Act (H.R. 2903/S. 1512)
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2021 · second_quarter · Q2
FY22 Congressional appropriations: -Increase NIH funds overall of at least $46.111 billion, providing a proportionate increase for the NIDDK of at least $157 million -Provide supplemental emergency funding of $10 billion for NIH and ensure dedicated support for the NIDDK to enable critical COVID-related research and to support research recovery from the impact of the pandemic. -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations kidney therapeutics and technologies Other: -Enact the Living Donor Protection Act (HR1255 S377) -Enact the Jack Reyonlds Medigap Expansion Act (HR1676) -Increase access to home dialysis through at-home support, increased education, and removal of other barriers to at-home care
FY22 Congressional appropriations: -Increase NIH funds overall of at least $46.111 billion, providing a proportionate increase for the NIDDK of at least $157 million -Provide supplemental emergency funding of $10 billion for NIH and ensure dedicated support for the NIDDK to enable critical COVID-related research and to support research recovery from the impact of the pandemic. -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations kidney therapeutics and technologies
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2021 · first_quarter · 1A
FY22 Congressional appropriations: -Increase NIH funds overall of at least $46.111 billion, providing a proportionate increase for the NIDDK of at least $157 million -Provide supplemental emergency funding of $10 billion for NIH and ensure dedicated support for the NIDDK to enable critical COVID-related research and to support research recovery from the impact of the pandemic. -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations kidney therapeutics and technologies Other: -Enact the Living Donor Protection Act (HR1255 S377) -Enact the Jack Reyonlds Medigap Expansion Act (HR1676) -Increase access to home dialysis through at-home support, increased education, and removal of other barriers to at-home care
FY22 Congressional appropriations: -Increase NIH funds overall of at least $46.111 billion, providing a proportionate increase for the NIDDK of at least $157 million -Provide supplemental emergency funding of $10 billion for NIH and ensure dedicated support for the NIDDK to enable critical COVID-related research and to support research recovery from the impact of the pandemic. -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations kidney therapeutics and technologies
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2021 · first_quarter · Q1
-Access to COVID-19 vaccines for dialysis patients in dialysis units, via a federal allocation
FY22 Congressional appropriations: -Increase NIH funds overall of at least $46.111 billion, providing a proportionate increase for the NIDDK of at least $157 million -Provide supplemental emergency funding of $10 billion for NIH and ensure dedicated support for the NIDDK to enable critical COVID-related research and to support research recovery from the impact of the pandemic. -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations kidney therapeutics and technologies Other: -Enact the Living Donor Protection Act (HR1255 S377) -Enact the Jack Reyonlds Medigap Expansion Act (HR1676) -Increase access to home dialysis through at-home support, increased education, and removal of other barriers to at-home care
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2020 · fourth_quarter · Q4
Support living donors through protected time off and no insurance discrimination through the "Living Donor Protection Act" (S. 511 and H.R. 1224) Provide lifetime immunosuppressive drug coverage for kidney transplant recipients "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2019" (S. 3353 and H.R. 5534) Expand access to home dialysis through reimbursement, other payments, and clarification of anti-kickback statutes Provide education regarding ASN's support for HHS proposed rule regarding organ procurement organization reform (42 CFR 486 or CMS-3380-P)
Increased NIH and NIDDK funding in FY2021 House and Senate LHHS Appropriations Bills increased funding for research into connections between COVID-19 and the kidney in potential fourth emergency supplemental COVID funding package $25M funding for KidneyX in FY2021 House and Senate LHHS Appropriations Bills Increased funding for innovative product development through KidneyX to support the COVID-19 response and better prepare our kidney care system for subsequent COVID waves or other emergency situations
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2020 · third_quarter · Q3
Urge Congress to support kidney patients and health professionals in the context of the COVID-19 pandemic by: -Prioritizing people with kidney transplants or receiving dialysis and their care teams for testing and PPE access -Increasing the supply of and funding for personal protective equipment (PPE) and COVID-19 tests in general -Expanding access to care for kidney patients via telehealth by waiving statutory limitations under 1881(b) -Protecting the nations kidney health workforce by retaining physicians and scientists currently in the U.S. and by expediting entrance of physicians into the country to support the COVID-19 pandemic response -Provide emergency funding for care partners to help in-center dialysis patients transition to home care -Creating parity between traditional telehealth reimbursement and reimbursement for audio-only interactions -Protecting the nation's healthcare workforce during the PHE by creating and preserving flexibility for international medical graduates to continue/start to practice in the US
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2020 · second_quarter · Q2
Support living donors through protected time off and no insurance discrimination through the "Living Donor Protection Act" (S. 511 and H.R. 1224) Provide lifetime immunosuppressive drug coverage for kidney transplant recipients "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2019" (S. 3353 and H.R. 5534) Expand access to home dialysis through reimbursement, other payments, and clarification of antikickback statutes
Urge Congress to support kidney patients and health professionals in the context of the COVID-19 pandemic by: -Prioritizing people with kidney transplants or receiving dialysis and their care teams for testing and PPE access -Increasing the supply of and funding for personal protective equipment (PPE) and COVID-19 tests in general -Expanding access to care for kidney patients via telehealth by waiving statutory limitations under 1881(b) -Protecting the nations kidney health workforce by retaining physicians and scientists currently in the U.S. and by expediting entrance of physicians into the country to support the COVID-19 pandemic response -Provide emergency funding for care partners to help in-center dialysis patients transition to home care -Creating parity between traditional telehealth reimbursement and reimbursement for audio-only interactions -Protecting the nation's healthcare workforce during the PHE by creating and preserving flexibility for international medical graduates to continue/start to practice in the US
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2020 · first_quarter · Q1
Increased NIH and NIDDK funding in FY2021 House and Senate LHHS Appropriations Bills increased funding for research into connections between COVID-19 and the kidney in potential fourth emergency supplemental COVID funding package $25M funding for KidneyX in FY2021 House and Senate LHHS Appropriations Bills and increased funding for innovative product development through KidneyX to support the COVID-19 response and better prepare our kidney care system for subsequent COVID waves or other emergency situations
Urge Congress to support kidney patients and health professionals in the context of the COVID-19 pandemic by: -Prioritizing people with kidney transplants or receiving dialysis and their care teams for testing and PPE access -Increasing the supply of and funding for personal protective equipment (PPE) and COVID-19 tests in general -Expanding access to care for kidney patients via telehealth by waiving statutory limitations under 1881(b) -Protecting the nations kidney health workforce by retaining physicians and scientists currently in the U.S. and by expediting entrance of physicians into the country to support the COVID-19 pandemic response -Provide emergency funding for care partners to help in-center dialysis patients transition to home care -Creating parity between traditional telehealth reimbursement and reimbursement for audio-only interactions
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2019 · fourth_quarter · Q4
Increased NIH and NIDDK funding in FY2020 House and Senate LHHS Appropriations Bills $25M funding for KidneyX in FY2020 House and Senate LHHS Appropriations Bills
$25M funding for KidneyX in FY2020 House and Senate LHHS Appropriations Bills Legislation to create a mechanism to add novel new devices to the ESRD PPS bundle Living Donor Protection Act (S. 511 and H.R. 1224) Organ Procurement Organization metrics reform (S. 2064 "Organ Procurement Optimization Act") Lifetime immunosuppressive drug coverage for kidney transplant recipients
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2019 · third_quarter · Q3
$25M funding for KidneyX in FY2020 House and Senate LHHS Appropriations Bills Legislation to create a mechanism to add novel new devices to the ESRD PPS bundle Living Donor Protection Act (S. 511 and H.R. 1224) Organ Procurement Organization metrics reform (S. 2064 "Organ Procurement Optimization Act") Lifetime immunosuppressive drug coverage for kidney transplant recipients
Increased NIH and NIDDK funding in FY2020 House and Senate LHHS Appropriations Bills $25M funding for KidneyX in FY2020 House and Senate LHHS Appropriations Bills
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2019 · second_quarter · Q2
Increased NIH and NIDDK funding in FY2020 House and Senate LHHS Appropriations Bills $25M funding for KidneyX in FY2020 House and Senate LHHS Appropriations Bills
$25M funding for KidneyX in FY2020 House and Senate LHHS Appropriations Bills Legislation to create a mechanism to add novel new devices to the ESRD PPS bundle Living Donor Protection Act (S. 511 and H.R. 1224) Organ Procurement Organization metrics reform (S. 2064 "Organ Procurement Optimization Act") Lifetime immunosuppressive drug coverage for kidney transplant recipients
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2019 · first_quarter · Q1
Increased NIH and NIDDK funding in FY2020 House and Senate LHHS Appropriations Bills $25M funding for KidneyX in FY2020 House and Senate LHHS Appropriations Bills
$25M funding for KidneyX in FY2020 House and Senate LHHS Appropriations Bills Legislation to create a mechanism to add novel new devices to the ESRD PPS bundle Living Donor Protection Act (S. 511 and H.R. 1224) Organ Procurement Organization metrics reform (forthcoming legislation) Lifetime immunosuppressive drug coverage for kidney transplant recipients
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2018 · fourth_quarter · Q4
Discussed important of investments in kidney research at NIH, VA, and encouraged cross-collaboration on kidney research Advocated to advance kidney research and innovation, including kidney disease prize competition and accelerator (KidneyX. Urged support for KidneyX program more generally.
Advocated in support of Living Donor Protection Act of 2017 (HR1270) Discussed concerns with Medicare Administrative Contractors (MACs) proposed Local Coverage Decisions (LCD) to limit dialysis more than 3 times per week and advocated for HR (HR 5721), a bill that would require more transparency on LCD decisions Proposed new care delivery models for comprehensive kidney care Need for a pathway to add new devices to the ESRD payment bundle Challenges with Organ Procurement Organization data integrity and evaluation framework
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2018 · third_quarter · Q3
Discussed important of investments in kidney research at NIH, VA, and encouraged cross-collaboration on kidney research Advocated to advance kidney research and innovation, including kidney disease prize competition and accelerator (KidneyX) including for FY2019 appropriations for KidneyX ($25 million). Urged Congressional support for KidneyX program more generally. Supported greater kidney research funding at NIH in general, and NIDDK in particular, for FY19 appropriations ($2.2 billion) Recommended Special Kidney Program for kidney research at NIDDK (appropriations)
Advocated in support of Living Donor Protection Act of 2017 (HR1270) Discussed concerns with Medicare Administrative Contractors (MACs) proposed Local Coverage Decisions (LCD) to limit dialysis more than 3 times per week and advocated for HR (HR 5721), a bill that would require more transparency on LCD decisions Proposed new care delivery models for comprehensive kidney care
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2018 · second_quarter · Q2
Discussed important of investments in kidney research at NIH, VA, and encouraged cross-collaboration on kidney research Advocated to advance kidney research and innovation, including kidney disease prize competition and accelerator (KidneyX) including for FY2019 appropriations for KidneyX ($25 million) Supported greater kidney research funding at NIH in general, and NIDDK in particular, for FY19 appropriations ($2.2 billion) Recommended Special Kidney Program for kidney research at NIDDK (appropriations)
Advocated in support of Living Donor Protection Act of 2017 (HR1270) Discussed concerns with Medicare Administrative Contractors (MACs) proposed Local Coverage Decisions (LCD) to limit dialysis more than 3 times per week and advocated for HR (HR 5721), a bill that would require more transparency on LCD decisions Proposed new care delivery models for comprehensive kidney care Supported allowing veterans in the VA healthcare system to receive transplants at non-VA facilities (VCTA bill and VICTOR Bill, ultimately passed as MISSION Act, S. 2372).
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2018 · first_quarter · Q1
Discussed important of investments in kidney research at NIH, VA, and encouraged cross-collaboration on kidney research Advocated to advance kidney research and innovation, including kidney disease prize competition and accelerator (KidneyX) including for FY2019 appropriations for KidneyX ($25 million) Supported greater kidney research funding at NIH in general, and NIDDK in particular, for FY19 appropriations ($2.2 billion) Recommended Special Kidney Program for kidney research at NIDDK (appropriations)
Advocated in support of Living Donor Protection Act of 2017 (HR1270) Supported several telehealth bills to permit home dialysis patients to interface with nephrologist including the CHRONIC Care Act (S. 870) and the Medicare Part B Improvement Act of 2017 (H.R.3178) Discussed concerns with Medicare Administrative Contractors (MACs) proposed Local Coverage Decisions (LCD) to limit dialysis more than 3 times per week and advocated for HR (HR 5721), a bill that would require more transparency on LCD decisions Proposed new care delivery models for comprehensive kidney care Supported allowing veterans in the VA healthcare system to receive transplants at non-VA facilities (VCTA bill, draft form)
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2017 · fourth_quarter · Q4
Discussed important of investments in kidney research at NIH, VA, and encouraged cross-collaboration on kidney research Advocated to advance kidney research and innovation, including kidney disease prize competition and accelerator Supported greater kidney research funding at NIH in general, and NIDDK in particular, for FY17 and FY18 appropriations Recommended Special Kidney Program for kidney research at NIDDK (appropriations)
Advocated in support of Living Donor Protection Act of 2017 (HR1270) Supported several telehealth bills to permit home dialysis patients to interface with nephrologist including the CHRONIC Care Act (S. 870) and the Medicare Part B Improvement Act of 2017 (H.R.3178) Discussed concerns with proposed Medicare Administrative Contractors (MACs) proposed Local Coverage Decisions to limit dialysis more than 3 times per week Proposed new care delivery models for comprehensive kidney care
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2017 · third_quarter · Q3
Discussed important of investments in kidney research at NIH, VA, and encouraged cross-collaboration on kidney research Advocated to advance kidney research and innovation, including kidney disease prize competition and accelerator Supported greater kidney research funding at NIH in general, and NIDDK in particular, for FY17 and FY18 appropriations Recommended Special Kidney Program for kidney research at NIDDK (appropriations)
Advocated in support of Living Donor Protection Act of 2017 (HR1270) Promoted ASN Guiding Principles for Health Reform, advocated against enactment of ACA repeal bill Supported several telehealth bills to permit home dialysis patients to interface with nephrologist including the CHRONIC Care Act (S. 870) and the Medicare Part B Improvement Act of 2017 (H.R.3178) Discussed concerns with proposed Medicare Administrative Contractors (MACs) proposed Local Coverage Decisions to limit dialysis more than 3 times per week
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2017 · second_quarter · Q2
Discussed important of investments in kidney research at NIH, VA, and encouraged cross-collaboration on kidney research Advocated to advance kidney research and innovation, including kidney disease prize competition and accelerator Supported greater kidney research funding at NIH in general, and NIDDK in particular, for FY17 and FY18 appropriations Recommended Special Kidney Program for kidney research at NIDDK (appropriations)
Advocated in support of Living Donor Protection Act of 2017 (HR1270) Promoted ASN Guiding Principles for Health Reform, advocated against enactment of ACA repeal bill Supported several telehealth bills to permit home dialysis patients to interface with nephrologist from home (H.R. 3178, H.R.2550, S.870)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2017 · first_quarter · Q1
Discussed important of investments in kidney research at NIH, VA, and encouraged cross-collaboration on kidney research Discussed need for/opportunities to advance kidney research and innovation, including kidney disease prize competition Supported greater kidney research funding at NIH in general, and NIDDK in particular, for FY17 and FY18 appropriations Recommended Special Kidney Program for kidney research at NIDDK (appropriations)
Advocated in support of Living Donor Protection Act of 2017 (HR1270)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FY22 Congressional appropriations: -Increase NIH funds, including $632 million increase for NIDDK to support kidney research and prioritizing research to improve the diagnosis of kidney diseases and health equity interventions -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $15 million
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
-Access to COVID-19 vaccines for dialysis patients in dialysis units, via a federal allocation
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
-Access to COVID-19 vaccines for dialysis patients in dialysis units, via a federal allocation
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
FY22 Congressional appropriations: -Increase NIH funds overall of at least $46.111 billion, providing a proportionate increase for the NIDDK of at least $157 million -Provide supplemental emergency funding of $10 billion for NIH and ensure dedicated support for the NIDDK to enable critical COVID-related research and to support research recovery from the impact of the pandemic. -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations kidney therapeutics and technologies
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Urge Congress to support kidney patients and health professionals in the context of the COVID-19 pandemic by: -Prioritizing people with kidney transplants or receiving dialysis and their care teams for testing and PPE access -Increasing the supply of and funding for personal protective equipment (PPE) and COVID-19 tests in general -Expanding access to care for kidney patients via telehealth by waiving statutory limitations under 1881(b) -Protecting the nations kidney health workforce by retaining physicians and scientists currently in the U.S. and by expediting entrance of physicians into the country to support the COVID-19 pandemic response -Provide emergency funding for care partners to help in-center dialysis patients transition to home care -Creating parity between traditional telehealth reimbursement and reimbursement for audio-only interactions -Protecting the nation's healthcare workforce during the PHE by creating and preserving flexibility for international medical graduates to continue/start to practice in the US -Expediting priority access to COVID-19 vaccines for people who are on dialysis and the staff and clinicians who care for them in dialysis units
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Support living donors through protected time off and no insurance discrimination through the "Living Donor Protection Act" (S. 511 and H.R. 1224) Provide lifetime immunosuppressive drug coverage for kidney transplant recipients "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2019" (S. 3353 and H.R. 5534) Expand access to home dialysis through reimbursement, other payments, and clarification of anti-kickback statutes Provide education regarding ASN's support for HHS proposed rule regarding organ procurement organization reform (42 CFR 486 or CMS-3380-P) Opposed proposed rule from ICE that would limit immigration, urging that requested the final rule exclude J-1 clinicians and scientists from the proposal.
Increased NIH and NIDDK funding in FY2021 House and Senate LHHS Appropriations Bills increased funding for research into connections between COVID-19 and the kidney in potential fourth emergency supplemental COVID funding package $25M funding for KidneyX in FY2021 House and Senate LHHS Appropriations Bills and $200M in emergency supplemental Increased funding for innovative product development through KidneyX to support the COVID-19 response and better prepare our kidney care system for subsequent COVID waves or other emergency situations
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE
Increased NIH and NIDDK funding in FY2021 House and Senate LHHS Appropriations Bills increased funding for research into connections between COVID-19 and the kidney in potential fourth emergency supplemental COVID funding package $25M funding for KidneyX in FY2021 House and Senate LHHS Appropriations Bills and $200M in emergency supplemental Increased funding for innovative product development through KidneyX to support the COVID-19 response and better prepare our kidney care system for subsequent COVID waves or other emergency situations
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Support living donors through protected time off and no insurance discrimination through the "Living Donor Protection Act" (S. 511 and H.R. 1224) Provide lifetime immunosuppressive drug coverage for kidney transplant recipients "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2019" (S. 3353 and H.R. 5534)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)